Jon Lecanda
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 11
- Cancer-related Molecular Pathways 5
- Cancer Cells and Metastasis 3
- Drug Transport and Resistance Mechanisms 2
-
- TGF-β signaling in diseases 5
- Ion Transport and Channel Regulation 3
- Ubiquitin and proteasome pathways 2
- Ion channel regulation and function 2
- Co-authors
- Jesús Prìeto (7 shared papers)Juan F. Medina (4 shared papers)Alfonso Calvo (3 shared papers)Diego Serrano (2 shared papers)Leslie I. Gold (5 shared papers)Jeffrey E. Green (1 shared paper)Víctor Segura (1 shared paper)Raúl Catena (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (4 papers)Experimental Cell Research (2 papers)Cell Cycle (2 papers)Cancer Research (2 papers)PLoS ONE (2 papers)
- Partner nations
- SpainUnited StatesIran
In The Last Decade
Jon Lecanda
17 papers receiving 562 citations
Peers
Comparison fields: 5 of 83
- Oncology 211
- Cancer Research 79
- Molecular Biology 312
- Hepatology 29
- Immunology 76
Countries citing papers authored by Jon Lecanda
This map shows the geographic impact of Jon Lecanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Lecanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Lecanda more than expected).
Fields of papers citing papers by Jon Lecanda
This network shows the impact of papers produced by Jon Lecanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Lecanda. The network helps show where Jon Lecanda may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon Lecanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 102 | |
| 2 | 2003 | 73 | |
| 3 | 2000 | 69 | |
| 4 | 2012 | 59 | |
| 5 | 2000 | 46 | |
| 6 | 2009 | 43 | |
| 7 | 2004 | 39 | |
| 8 | 2007 | 31 | |
| 9 | 2000 | 27 | |
| 10 | 2012 | 26 | |
| 11 | 2010 | 25 | |
| 12 | 2003 | 15 | |
| 13 | 2016 | 11 | |
| 14 | 2016 | 2 | |
| 15 | 2008 | 2 | |
| 16 | 2000 | 2 | |
| 17 | 2010 | 1 |
About Jon Lecanda
Jon Lecanda is a scholar working on Oncology, Molecular Biology, Surgery, Public Health, Environmental and Occupational Health and Cell Biology, having authored 17 papers that have together received 573 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (5 papers), Cancer-related Molecular Pathways (5 papers), Pancreatic function and diabetes (4 papers), Ion Transport and Channel Regulation (3 papers), Cancer Cells and Metastasis (3 papers), Ubiquitin and proteasome pathways (2 papers), Ion channel regulation and function (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Oncology (211 citations), Cancer Research (79 citations), Molecular Biology (312 citations), Hepatology (29 citations) and Immunology (76 citations). Jon Lecanda has collaborated with scholars based in Spain, United States and Iran. Frequent co-authors include Jesús Prìeto, Juan F. Medina, Alfonso Calvo, Diego Serrano, Leslie I. Gold, Jeffrey E. Green, Víctor Segura, Raúl Catena, Raquel Urtasun and Yonglian Sun. Their work appears in journals such as Biochemical and Biophysical Research Communications, Experimental Cell Research, Cell Cycle, Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.